Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 1/20 | 0.64 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.64 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.64 |
| ▸ | SLC29A1 | Q99808 | 3/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | NT5E | P21589 | 1/20 | 0.61 |
| ▸ | UBA6 | A0AVT1 | 1/20 | 0.60 |
| ▸ | ATG7 | O95352 | 1/20 | 0.60 |
| ▸ | UBA7 | P41226 | 1/20 | 0.60 |
| ▸ | NAE1 | Q13564 | 1/20 | 0.60 |
| ▸ | UBA3 | Q8TBC4 | 1/20 | 0.60 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.60 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.60 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.60 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.59 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1796735 | 0.92 | DNPH1 (0.75) | DNPH1DNMT1DNMT3BSLC29A1ADORA3 | |
| SCHEMBL17889870 | 0.92 | DNPH1 (0.75) | DNPH1DNMT1DNMT3BSLC29A1ADORA3 | |
| SCHEMBL1794568 | 0.91 | SLC29A1 (0.64) | DNPH1SLC29A1ADORA3TP53TDP1 | |
| SCHEMBL12652413 | 0.91 | SLC29A1 (0.64) | DNPH1SLC29A1ADORA3TP53TDP1 | |
| SCHEMBL1796050 | 0.91 | SLC29A1 (0.64) | DNPH1SLC29A1ADORA3TP53TDP1 | |
| SCHEMBL32662526 | 0.90 | ADORA3 (0.76) | DNPH1SLC29A1ADORA3TP53TDP1 | |
| SCHEMBL1799750 | 0.87 | SLC29A1 (0.60) | DNPH1SLC29A1ADORA3TP53TDP1 | |
| SCHEMBL1797185 | 0.86 | ADORA3 (0.75) | DNPH1SLC29A1ADORA3TP53TDP1 | |
| SCHEMBL32661694 | 0.86 | UBA6 (0.63) | DNPH1SLC29A1ADORA3TP53TDP1 | |
| SCHEMBL17889823 | 0.86 | ADORA3 (0.67) | DNPH1SLC29A1ADORA3TP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015592-A1 | NEDDYLATION-ACTIVATING ENZYME INHIBITORS AS VIRAL SENSITIZERS AND USES THEREOF | OTTAWA HOSPITAL RESEARCH INSTITUTE (CA) | 2026-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015592-A1 | NEDDYLATION-ACTIVATING ENZYME INHIBITORS AS VIRAL SENSITIZERS AND USES THEREOF | NAE1, NEDD8, UBA3 | DNPH1 730/4885DNMT1 593/4885DNMT3B 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.